- Sections
- C - Chimie; métallurgie
- C07D - Composés hétérocycliques
- C07D 263/40 - Un atome d'oxygène lié en position 4
Détention brevets de la classe C07D 263/40
Brevets de cette classe: 27
Historique des publications depuis 10 ans
2
|
1
|
1
|
5
|
2
|
0
|
2
|
3
|
0
|
0
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
Proprétaire |
Total
|
Cette classe
|
---|---|---|
North Carolina State University | 1492 |
8 |
AstraZeneca AB | 3042 |
2 |
The Arizona Board of Regents on Behalf of the University of Arizona | 1906 |
2 |
Mitsubishi Tanabe Pharma Corporation | 579 |
2 |
F. Hoffmann-La Roche AG | 7958 |
1 |
Hoffmann-La Roche Inc. | 3060 |
1 |
Board of Regents, The University of Texas System | 5370 |
1 |
Takeda Pharmaceutical Company Limited | 2961 |
1 |
The Board of Regents for Oklahoma State University | 165 |
1 |
Dompé Farmaceutici S.p.A. | 239 |
1 |
Dompe S.p.A. | 13 |
1 |
Nereus Pharmaceuticals, Inc. | 19 |
1 |
Shanghai Institute of Materia Medica, Chinese Academy of Sciences | 762 |
1 |
Vanderbilt University | 1731 |
1 |
The Board of Regents of the University of Texas System | 2043 |
1 |
The National Center for Drug Screening | 6 |
1 |
Suzhou Elite New Pharmaceutical Research and Development Co., Ltd. | 1 |
1 |
Autres propriétaires | 0 |